首页> 外国专利> METHODS FOR PREVENTING CARDIAC HYPERTROPHY AND HEART FAILURE BY INHIBITION OF MEF2 TRANSCRIPTION FACTOR

METHODS FOR PREVENTING CARDIAC HYPERTROPHY AND HEART FAILURE BY INHIBITION OF MEF2 TRANSCRIPTION FACTOR

机译:抑制MEF2转录因子预防心脏肥大和心力衰竭的方法

摘要

The present invention relates to cardiac hypertrophy. More particularly, the present invention defines the molecular events linking calcium stimulation to cardiac hypertrophy. More specifically, the present invention shows that Ca++ stimulation of the hypertrophic response is mediated through MEF2. Thus, the present invention provides methods of treating cardiac hypertrophy as well as transgenic constructs for preparing transgenic animals. Further provided are methods of using the transgenic animals of the present invention, or cells isolated therefrom, for the detection of compounds having therapeutic activity toward cardiac hypertrophy.
机译:本发明涉及心脏肥大。更具体地,本发明定义了将钙刺激与心脏肥大联系起来的分子事件。更具体地,本发明表明Ca ++对肥大反应的刺激是通过MEF2介导的。因此,本发明提供了治疗心脏肥大的方法以及用于制备转基因动物的转基因构建体。还提供了使用本发明的转基因动物或从其分离的细胞来检测对心脏肥大具有治疗活性的化合物的方法。

著录项

  • 公开/公告号EP1137771A2

    专利类型

  • 公开/公告日2001-10-04

    原文格式PDF

  • 申请/专利权人 BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM;

    申请/专利号EP19990971848

  • 发明设计人 OLSON ERIC N.;

    申请日1999-11-10

  • 分类号C12N15/11;A61K39/395;A01K67/027;C12Q1/68;C07K14/47;C12N15/62;A61P9/00;

  • 国家 EP

  • 入库时间 2022-08-22 01:14:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号